BioPharmSignal logoBioPharmSignal

Biotech News

MATERIALISE AANDELENINKOOPPROGRAMMA

Materialise (MTLS)MaterialiseCompany update

Leuven – 13 juli 2026 – 22h00 CET Gereglementeerde informatie 1 Materialise rapporteert over de voortgang van haar op 30 oktober 2025 aangekondigde aandeleninkoopprogramma. 13 July 2026 – Materialise NV (Euronext: MTLS) (Nasdaq: MTLS) (“Materialise”) (“de

Related news

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-05-16 02:00 EST

Materialise houdt jaarlijkse aandeelhoudersvergadering op 16 juni 2026

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-20 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-07-13 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-07-06 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

Stock data

Close
6.75 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States